Which Emerging Trends Are Driving The Albumin Excipient Market Toward $6.64 Billion By 2029?
Claim 30% Off Global Market Reports With Code ONLINE30 – Insights on Tariff Effects, Global Trade, and Industry Disruptors
#What Is The Present And Forecasted Size Of The Albumin Excipient Market?#_x000D_
In recent years, the albumin excipient market has exhibited strong growth. The market size is projected to expand from $4.85 billion in 2024 to $5.15 billion in 2025, boasting a compound annual growth rate (CAGR) of 6.1%. The significant growth during the historical period was brought about by the expansion of the biopharmaceutical industry, wider acceptance of biologics, increasing occurrence of chronic diseases, advancements in clinical procedures, innovation in drug development, and an intensifying focus on drug delivery._x000D_
_x000D_
In the coming years, the albumin excipient market is projected to experience robust growth. It is anticipated to increase to $6.64 billion in 2029, with a compound annual growth rate (CAGR) of 6.6%. The projected growth within this period can be linked to the consistent expansion of biopharmaceuticals, an escalating pipeline of biologics, an aged population that’s on the rise, global efforts towards vaccination, and an upsurge in the investments towards drug development. Key trends expected throughout the forecast period encompass biodegradable and biocompatible features, alliances and partnerships within research, compliance with regulatory and quality standards, applications in cell therapy, and the provision of customization and tailored solutions._x000D_
_x000D_
#Get A Free Sample Of The Report:#_x000D_
https://www.thebusinessresearchcompany.com/sample.aspx?id=10672&type=smp_x000D_
_x000D_
#Which Factors Are Steering Growth In The Albumin Excipient Market?#_x000D_
The escalating incidence of long-term illnesses is anticipated to boost the expansion of the albumin excipient market. Chronic diseases are conditions that persist for three months or longer and can progressively worsen over time. Albumin, the most copious circulating protein in plasma, is employed as a blood volume enhancer and serves as a multifaceted protein transporter for drug delivery and enhancement of the pharmacokinetic profile of peptide or protein-centered drugs. It plays a key role in treating a variety of ailments, like cancer and diabetes. For example, the World Health Organization, a Switzerland-originated branch of the United Nations, predicted in February 2024 that cancer cases will exceed 35 million by 2050, which would be a 77% surge compared to the approximate 20 million cases in 2022. Hence, the escalating incidence of chronic illnesses motivates the growth of the albumin excipient market._x000D_
_x000D_
#What Are The Main Segment Classifications In The Albumin Excipient Market?#_x000D_
The albumin excipient market covered in this report is segmented – _x000D_
_x000D_
1) By Product: Human Serum Albumin, Recombinant Albumin_x000D_
2) By End-Users: Pharmaceutical And Biotechnology Industry, Research Institutes, Other End Users_x000D_
_x000D_
Subsegments:_x000D_
1) By Human Serum Albumin: 5% Human Serum Albumin, 20% Human Serum Albumin_x000D_
2) By Recombinant Albumin: Recombinant Human Serum Albumin, Recombinant Bovine Serum Albumin_x000D_
_x000D_
#How Are Industry Trends Steering The Expansion Of The Albumin Excipient Market?#_x000D_
Prominent organizations functioning in the albumin excipient sector are leveraging the method of strategic partnering to serve vital biotechnology and pharmaceutical industries. This involves companies using each other’s strengths and assets for mutual gains and growth. For example, in October 2023, ARTES Biotechnology GmbH, a biotechnological company based in Germany, formed a strategic alliance with Basic Pharma, a pharmaceutical organization based in the Netherlands, to further the production of recombinant protein. The objective of this collaboration is to enhance the production of pharmaceutical recombinant protein by improving the supply chain efficiency and shortening the time-to-market for new releases._x000D_
_x000D_
#Who Are The Major Stakeholders Operating In The Albumin Excipient Market?#_x000D_
Major companies operating in the albumin excipient market include Albumin Therapeutics LLC, Biotest AG, CSL Behring,Grifols S.A., HiMedia Laboratories LLC, InVitria Inc., Medxbio Pte Ltd., Octapharma AG, RayBiotech Inc., SeraCare Life Sciences Inc., Sigma-Aldrich Pty. Ltd., Hualan Biological Engineering Inc., Kedrion Biopharma, LFB USA Inc., Shanghai RAAS Blood Products Co. Ltd., Baxter International Inc., Merck KGaA, Thermo Fisher Scientific Inc., Albumedix A/S, Bio Products Laboratory Ltd., Shire Plc., Ventria Bioscience Inc., Novartis AG, China Biologic Products Holdings Inc., ProMetic Life Sciences Inc., Sanquin, Biopharma, Takeda Pharmaceutical Company Limited, FUJIFILM Irvine Scientific Inc. _x000D_
_x000D_
#Access The Complete Report Here:#_x000D_
https://www.thebusinessresearchcompany.com/report/albumin-excipient-global-market-report_x000D_
_x000D_
#What Are The Emerging Regional Trends Driving The Albumin Excipient Market?#_x000D_
North America was the largest region in the Albumin Excipient market in 2024.Asia-Pacific is expected to be the fastest-growing region in the global albumin excipient market report during the forecast period. The regions covered in the albumin excipient market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa_x000D_
_x000D_
#Customize Your Report Here:#_x000D_
https://www.thebusinessresearchcompany.com/customise?id=10672&type=smp_x000D_
_x000D_
#About The Business Research Company:#_x000D_
_x000D_
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game._x000D_
_x000D_
#Get in touch with us:#_x000D_
_x000D_
The Business Research Company: https://www.thebusinessresearchcompany.com/_x000D_
Americas +1 310-496-7795_x000D_
Asia +44 7882 955267 & +91 8897263534_x000D_
Europe +44 7882 955267_x000D_
Email us at info@tbrc.info_x000D_
_x000D_
#Follow us on:#_x000D_
_x000D_
LinkedIn: https://in.linkedin.com/company/the-business-research-company_x000D_
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ_x000D_
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
